Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

ASPARGO LABS, INC.

ClinicalTrials.gov lists ASPARGO LABS, INC. as lead sponsor of 11 trials. It has 30 active development programs and 1 approved asset.

US Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Disease areas Disease areas 2 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 2 Active development programs Active development programs 30 Approved assets Approved assets 1 Latest dated events Latest dated events 11 Biomarker capability evidence Biomarker capability evidence 16 Disease areas Disease areas 2 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 2 Active development programs Active development programs 30 Approved assets Approved assets 1 Latest dated events Latest dated events 11 Biomarker capability evidence Biomarker capability evidence 16

Rows recorded per section (log scale)

18 sections measured, none recorded

This page covers ASPARGO LABS, INC.: 11 lead-sponsored trials and 1 legal-entity registration.

Get the ASPARGO LABS, INC. report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (2)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Erectile Dysfunction 5
Sexual Dysfunction, Physiological 5

Trials by start year as sponsor or collaborator (2)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 9
2025 2

No forecast is made for this organization: it averages 2.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Active development programs (30)

Shown in this order: max phase, then active trials.

Active development programs
Drug Disease area Max phase Trials
Aristo Sildaristo Sexual Dysfunction, Physiological Phase 2 1
Hello Cake ED Cake Meds Erectile Dysfunction Phase 2 1
Hello Cake ED Cake Meds Sexual Dysfunction, Physiological Phase 2 1
Aristo Sildaristo Erectile Dysfunction Phase 2 1
Hims Hard Mints Erectile Dysfunction Phase 2 1

Showing 5 of 30 active programs.

Start your 14-day trial Email me all 30 active programs as a PDF

Approved assets (1)

Approved assets
Drug Trials
Viagra 1

Latest dated events (11)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-07-15 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-06-15 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-05-15 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-04-15 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-04-15 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 11 events.

Start your 14-day trial Email me all 11 events as a PDF

Biomarker capability evidence (16)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
F2 Trial sponsor Named in trial exclusion criteria
F2 Trial sponsor Named in trial exclusion criteria
PDE5A Trial sponsor Named in trial exclusion criteria
PDE5A Trial sponsor Named in trial exclusion criteria
PDE5A Trial sponsor Named in trial exclusion criteria

Showing 5 of 16 evidence rows.

Start your 14-day trial Email me all 16 evidence rows as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sponsor delivery record, journals published in, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, and biomarkers this organization publishes on.